Investigational Drug Information for Aramchol
✉ Email this page to a colleague
What is the development status for investigational drug Aramchol?
Aramchol is an investigational drug.
There have been 13 clinical trials for Aramchol.
The most recent clinical trial was a Phase 2 trial, which was initiated on September 23rd 2019.
The most common disease conditions in clinical trials are Non-alcoholic Fatty Liver Disease, Liver Diseases, and Fatty Liver. The leading clinical trial sponsors are Galmed Pharmaceuticals Ltd, Galmed Research and Development, Ltd., and Diamond Pharma Services Regulatory Affairs Consultancy.
There are eleven US patents protecting this investigational drug and three hundred and fifty-five international patents.
Summary for Aramchol
| US Patents | 11 |
| International Patents | 355 |
| US Patent Applications | 137 |
| WIPO Patent Applications | 154 |
| Japanese Patent Applications | 27 |
| Clinical Trial Progress | Phase 2 (2019-09-23) |
| Vendors | 36 |
Recent Clinical Trials for Aramchol
| Title | Sponsor | Phase |
|---|---|---|
| A Study Evaluating the Safety, Tolerability, and Efficacy of Aramchol Meglumine in Primary Sclerosing Cholangitis | Virginia Commonwealth University | Phase 2 |
| A Study Evaluating the Safety, Tolerability, and Efficacy of Aramchol Meglumine in Primary Sclerosing Cholangitis | Galmed Research and Development, Ltd. | Phase 2 |
| An Open-Label, Two-Part Study Designed to Assess the Absolute Bioavailability and Mass Balance of Aramchol | Quotient Sciences | Phase 1 |
Clinical Trial Summary for Aramchol
Top disease conditions for Aramchol
Top clinical trial sponsors for Aramchol
US Patents for Aramchol
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Aramchol | ⤷ Sign Up | Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonists | Bristol-Myers Squibb Company (Princeton, NJ) Syngene International Limited (Bangalore, Karnataka, IN) | ⤷ Sign Up |
| Aramchol | ⤷ Sign Up | Controlled release dosage form | TRIASTEK, INC. (Nanjing, CN) | ⤷ Sign Up |
| Aramchol | ⤷ Sign Up | Monocyclic compound | Takeda Pharmaceutical Company Limited (Osaka, JP) | ⤷ Sign Up |
| Aramchol | ⤷ Sign Up | Bicyclic compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (Osaka, JP) | ⤷ Sign Up |
| Aramchol | ⤷ Sign Up | FXR (NR1H4) modulating compounds | Gilead Sciences, Inc. (Foster City, CA) | ⤷ Sign Up |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Aramchol
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Aramchol | Argentina | AR108838 | 2036-06-21 | ⤷ Sign Up |
| Aramchol | Australia | AU2017281439 | 2036-06-21 | ⤷ Sign Up |
| Aramchol | Australia | AU2021209334 | 2036-06-21 | ⤷ Sign Up |
| Aramchol | Brazil | BR112018076558 | 2036-06-21 | ⤷ Sign Up |
| Aramchol | Canada | CA3029202 | 2036-06-21 | ⤷ Sign Up |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
